Condition: Ischemic Stroke, Acute · TIA · Symptomatic Intracranial Artery Stenosis · Sponsor: Beijing Tiantan Hospital
This is a multicenter, double-blind, double-dummy, randomized clinical trial comparing the efficacy and safety of tirofiban versus placebo in preventing recurrence of stroke for patients with intracranial artery stenosis and high-risk acute non-disabling cerebrovascular events.
This description comes directly from the study's public registry record.
Yongjun Wang · 13911172565 · yongjunwang@ncrcnd.org.cn
Jing Jing · 15810312511 · jingj_bjttyy@163.com
Always discuss trial participation with your own doctor first.
| The 2nd Affiliated Hospital of Harbin Medical University | Harbin, Heilongjiang, China | Recruiting |
| People's Hospital of Qihe County | Dezhou, Shandong, China | Recruiting |
| Liaocheng People's Hospital（Liaocheng Brain Hospital） | Liaocheng, Shandong, China | Recruiting |
| Third People's Hospital of Liaocheng | Liaocheng, Shandong, China | Recruiting |
| Yantai Penglai traditional Chinese medicine hospital | Yantai, Shandong, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06319846